Company / Cost of Revenue
Entera Bio Ltd. Cost of Revenue History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$172.0K
FY2025
5-year range
$0 / $373.0K
FY2021-FY2025
Trend
-
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cost of Revenue returned to growth in FY2025 after 2 years of decline, reaching $172,000.
Based on SEC 10-K filings.
$172,000 in FY2025 with a 3-year CAGR of -22.7%.
Increased from $101,000 to $172,000 over the past 2 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- -22.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -22.7%, indicating a declining trend.
- Peak cost of revenue was recorded in FY2022.
- Lowest cost of revenue in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $172.0K | - |
| FY2024 | $0 | -100.0% |
| FY2023 | $101.0K | -72.9% |
| FY2022 | $373.0K | +24.3% |
| FY2021 | $300.0K | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026